Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating ...

Hudson Regional Hospital’s Cardiac Catheterization Lab has earned NJ State Department of Health approval for STEMI ...

Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring.

Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring. Late ...

Researchers from the School of Engineering of the Hong Kong University of Science and Technology (HKUST) have successfully ...

The global electrophysiology market is forecasted to grow at a 7.6% CAGR, reaching USD 9.08 billion by 2034. The increasing ...

Artificial intelligence (AI) models, particularly artificial neural networks and machine learning, outperform traditional ...

ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of ...

Pilot-phase results of UroShield clinical trial highlight potential to reduce catheter-associated complications and transform ...

A computerized clinical decision support tool implemented as a diagnostic stewardship intervention led to an approximate 50% decrease in urine culture testing for patients with a urinary catheter, ...

Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional ...